ARDT · XBRL financial data

Ardent Health financial statements, every quarter

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ARDT's year ends in late December)

In millions of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	1,471	1,450	1,606*	1,497	1,645	1,577	1,605*	1,602	1,622
General and administrative	29	34	37*	35	33	37	37*	49	61
Income tax expense (benefit)	15	11	26*	15	26	(3)	18*	16	9
Net income (loss)	43	26	114*	41	73	(23)	45*	40	17
Earnings per share, basic USD per share	0.34	0.19	0.81*	0.30	0.52	(0.17)	0.32*	0.28	0.12
Earnings per share, diluted USD per share	0.34	0.19	0.81*	0.29	0.52	(0.17)	0.32*	0.28	0.12
Weighted average shares, basic millions of shares	126	137	140*	140	140	141	141*	141	142
Weighted average shares, diluted millions of shares	126	138	141*	141	142	141	142*	142	143

Fiscal quarters (ARDT's year ends in late December)

In millions of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	335	563	557	495	541	609	710	610	724
Accounts receivable	721	706	743	777	759	729	686	686	696
Inventory	105	108	115	120	118	122	119	120	116
Total current assets	1,501	1,691	1,833	1,761	1,877	1,957	2,059	2,020	2,055
Property and equipment, net	807	815	862	857	870	888	—	—	—
Goodwill	852	852	852	877	878	878	879	879	879
Total assets	4,609	4,800	4,956	4,911	5,027	5,154	5,290	5,253	5,280
Accounts payable	371	369	401	372	364	382	458	420	430
Current portion of long-term debt	11	12	9	18	19	19	23	38	29
Total current liabilities	909	887	945	830	881	943	1,047	951	976
Long-term debt	1,082	1,084	1,086	1,091	1,090	1,087	1,076	1,073	1,073
Lease liability, non-current	—	—	1,141	—	—	—	1,165	—	—
Total liabilities	3,446	3,413	3,434	3,347	3,381	3,523	3,605	3,522	3,539
Retained earnings	225	252	366	407	480	457	502	541	558
Total stockholders' equity	740	1,006	1,131	1,175	1,255	1,238	1,288	1,337	1,351
Total liabilities and equity	4,609	4,800	4,956	4,911	5,027	5,154	5,290	5,253	5,280
Common shares outstanding (cover page) millions of shares	143	143	143	143	143	143	143	143	141

Fiscal quarters (ARDT's year ends in late December)

In millions of dollars	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	43	26	114*	41	73	(23)	45*	40	17
Depreciation and amortization	36*	37*	38*	36	39*	39*	41*	43	41*
Net cash from operating activities	120*	90*	120*	(25)	117*	154*	223*	(60)	197*
Net cash from investing activities	(39)*	(45)*	(105)*	(23)	(46)*	(59)*	(86)*	(28)	(39)*
Dividends paid	—	—	year only	—	—	—	—	—	—
Proceeds from long-term debt	1*	2*	0*	0	0*	0*	0*	—	—
Repayments of long-term debt	101*	1*	2*	1	2*	2*	3*	4	3*
Net cash from financing activities	(120)*	183*	(20)*	(14)	(26)*	(27)*	(37)*	(12)	(43)*
Net change in cash	(38)*	229*	(6)*	(62)	46*	69*	100*	(100)	115*

SIC 8062 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8062 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Ardent Health	724	1,622	197*	141.0M	Q2 FY26 10-QJun 30, 2026
Community Health Systems	155	2,757	154*	141.0M	Q3 FY26 10-QSep 30, 2026
Pediatrix Medical Group	312	501	117*	78.1M	Q3 FY26 10-QSep 30, 2026
Select Medical Holdings	26	1,421	38	124.0M	Q1 FY26 10-QMar 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.